Mark Mark AguillardIhab
VP & GM, Oncology Business Unit
Mark Aguillard joined Epic Sciences as the General Manager of the Oncology Business Unit in 2021 with over 20 years of experience driving commercial growth in the genomics, pharmaceutical, and biotechnology industries. Prior to joining Epic, he served in commercial leadership roles with Myriad Genetics, binx health, OmniSeq, and Eli Lilly & Company with a breadth of commercial experience in leading sales, marketing, customer service, and managed care teams across oncology and women’s health. Over the course of his career, Mr. Aguillard launched the first pan-cancer hereditary cancer panel, myRisk, built multiple sales and marketing teams, led the integration of two multi-million dollar companies, and secured coverage and reimbursement for multiple novel diagnostic products. Mr. Aguillard received his Bachelors in Business Administration with a major in Finance from Texas Tech University.